Wellgistics Health, Inc. (NASDAQ:WGRX – Get Free Report) was the recipient of a significant decrease in short interest during the month of May. As of May 29th, there was short interest totaling 444,588 shares, a decrease of 95.6% from the May 14th total of 10,201,616 shares. Approximately 24.2% of the shares of the stock are sold short. Based on an average trading volume of 3,073,607 shares, the days-to-cover ratio is presently 0.1 days.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on WGRX shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Wellgistics Health in a report on Friday, March 27th. Wall Street Zen raised shares of Wellgistics Health to a “sell” rating in a report on Saturday, May 30th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.
Wellgistics Health Trading Down 0.3%
Institutional Trading of Wellgistics Health
A number of institutional investors and hedge funds have recently added to or reduced their stakes in WGRX. XTX Topco Ltd grew its position in shares of Wellgistics Health by 195.1% during the 4th quarter. XTX Topco Ltd now owns 106,087 shares of the company’s stock worth $42,000 after buying an additional 70,137 shares during the period. Raymond James Financial Inc. grew its position in Wellgistics Health by 593.8% in the 3rd quarter. Raymond James Financial Inc. now owns 58,421 shares of the company’s stock valued at $52,000 after purchasing an additional 50,000 shares during the period. Geode Capital Management LLC grew its position in Wellgistics Health by 81.0% in the 4th quarter. Geode Capital Management LLC now owns 487,383 shares of the company’s stock valued at $195,000 after purchasing an additional 218,170 shares during the period. Finally, Heights Capital Management Inc. acquired a new stake in Wellgistics Health in the 3rd quarter valued at $2,588,000.
Wellgistics Health Company Profile
Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
See Also
- Five stocks we like better than Wellgistics Health
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
- Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion
Receive News & Ratings for Wellgistics Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wellgistics Health and related companies with MarketBeat.com's FREE daily email newsletter.
